Search hospitals > Ohio > Youngstown
Saint Elizabeth Youngstown Hospital
Claim this profileYoungstown, Ohio 44504
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
111 reported clinical trials
3 medical researchers
Summary
Saint Elizabeth Youngstown Hospital is a medical facility located in Youngstown, Ohio. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Saint Elizabeth Youngstown Hospital is involved with conducting 111 clinical trials across 244 conditions. There are 3 research doctors associated with this hospital, such as Howard M. Gross, James Kim, MD, and jawad Francis.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Howard M. GrossKettering Medical Center6 years of reported clinical research
Expert in Breast Cancer
Expert in Breast cancer
134 reported clinical trials
200 drugs studied
James Kim, MDSaint Elizabeth Youngstown Hospital3 years of reported clinical research
Studies Lung Cancer
Studies Pancreatic Cancer
1 reported clinical trial
1 drug studied
jawad FrancisSt. Elizabeth Youngstown Hospital3 years of reported clinical research
Studies Breast Cancer
1 reported clinical trial
5 drugs studied
Clinical Trials running at Saint Elizabeth Youngstown Hospital
Lung Cancer
Bladder Cancer
Breast Cancer
Melanoma
Kidney Cancer
Prostate Cancer
Breast cancer
Cancer
Esophageal cancer
Multiple Myeloma
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Elizabeth Youngstown Hospital?
Saint Elizabeth Youngstown Hospital is a medical facility located in Youngstown, Ohio. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Saint Elizabeth Youngstown Hospital is involved with conducting 111 clinical trials across 244 conditions. There are 3 research doctors associated with this hospital, such as Howard M. Gross, James Kim, MD, and jawad Francis.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.